U.S. FDA Finds Quality Lapses At Biocon’s Bengaluru Facility
A technician works at Biocon Ltd.’s cancer drug facility in Bangalore (Photographer: Namas Bhojani/Bloomberg) 

U.S. FDA Finds Quality Lapses At Biocon’s Bengaluru Facility

An inspection by the U.S. health regulator revealed ten lapses in quality at Biocon Ltd.’s manufacturing facility in Bengaluru. The observations pointed at aseptic practices, adding to the biotechn...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.